Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi.
Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than ea...
Main Authors: | Chelsey Porter Erlank, Gracious Ali, Frehiwot Birhanu, Melinda Stanley, Jessie Salamba Chirwa, Fannie Kachale, Andrews Gunda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLOS Global Public Health |
Online Access: | https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0002057&type=printable |
Similar Items
-
Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi
by: Gracious Ali, et al.
Published: (2023-03-01) -
The correlation between the amount of weight gain and physical activity levels in Depot Medroxyprogesterone Acetate (DMPA) users
by: Zumroh Hasanah, et al.
Published: (2025-03-01) -
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022-01-01) -
The effect of <i>Vigna unguiculata</i> on the estrogen receptor-α expression and the endometrial thickness in rats treated with depot medroxyprogesterone acetate (DMPA)
by: Rizki Fitrianingtyas, et al.
Published: (2023-12-01) -
Depo Medroxyprogesterone Acetate (DMPA): Long-Term Effects on Menstrual Cycle Disorders
by: Nurhayati Nurhayati, et al.
Published: (2023-04-01)